rethinkPeptides Search
Menu
Study breakdown

Cystine-Knot Peptide Scaffold Used for Cancer PET Imaging: Cyclotides as Diagnostic Tools

evidence
The takeaway

A cystine-knot peptide based on agouti-related protein was labeled with 64Cu for PET imaging of tumors expressing αvβ3 integrin, demonstrating cyclotide scaffolds as stable cancer diagnostic imaging agents.

Key finding

A cystine-knot peptide based on agouti-related protein was labeled with 64Cu for PET imaging of tumors expressing αvβ3 integrin, demonstrating cycloti

What the researchers found

A cystine-knot peptide based on agouti-related protein was labeled with 64Cu for PET imaging of tumors expressing αvβ3 integrin, demonstrating cyclotide scaffolds as stable cancer diagnostic imaging agents.

Why it matters

Relevant for peptide research.

How the study worked

research study.

What this study cannot tell us

See abstract.

How to read the evidence

emerging evidence.

When this study was published

Published in 2010.

The bigger picture

Advances peptide research.

Questions still open

  • Further research needed.

Common questions

What was studied?
Cystine-Knot Peptide Scaffold Used for Cancer PET Imaging: Cyclotides as Diagnostic Tools
What was found?
A cystine-knot peptide based on agouti-related protein was labeled with 64Cu for PET imaging of tumors expressing αvβ3 integrin, demonstrating cyclotide scaffolds as stable cancer diagnostic imaging agents.

Read the original research

Evaluation of a (64)Cu-labeled cystine-knot peptide based on agouti-related protein for PET of tumors expressing alphavbeta3 integrin.

Journal of nuclear medicine : official publication, Society of Nuclear Medicine, 51(2), 251-258

Citation

Jiang, Lei; Kimura, Richard H; Miao, Zheng; Silverman, Adam P; Ren, Gang; Liu, Hongguang; Li, Peiyong; Gambhir, Sanjiv Sam; Cochran, Jennifer R; Cheng, Zhen. (2010). Evaluation of a (64)Cu-labeled cystine-knot peptide based on agouti-related protein for PET of tumors expressing alphavbeta3 integrin.. Journal of nuclear medicine : official publication, Society of Nuclear Medicine, 51(2), 251-258. https://doi.org/10.2967/jnumed.109.069831